References
- Feldman HA, Goldstein I, Hatzichristau DG, Krane RJ, Mc Kinlay JB. Impotence and its medical and psycho-logical correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
- Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802–13.
- Hsieh JT, Lue TF, Muller SC. The influence of blood flow and blood pressure on penile erection. Int J Impot Res 1989; 1: 35–42.
- Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculo-genic impotence evaluated by high-resolution ultrason-ography and pulsed Doppler analysis. Radiology 1985; 155: 777–81.
- Meuleman EJ, Diemont WL. Investigation of erectile dysfunction: diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995; 22: 803–
- Lue TF, Broderick G. Evaluation and nonsurgical treatment of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED Jr, Weia AJ, eds. Campbell's urology, 17th edn., Vol. 2. Philadelphia, PA: Saunders, 1998: 1181–214.
- Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roerbom CG, et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urologi-cal Association. J Urol 1996; 156: 2007–11.
- Jarow JP, Nana-Sinkam P. Sabbagh M, Eskew A. Outcome analysis of goal directed therapy for impotence. J Urol 1996; 155: 1609–12.
- Padma-Nathan H, Guiliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001; 28: 321–34.
- Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. Br Med J 2000; 321: 499–503.
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile function. Urology 1997; 49: 822–30.
- Patel U, Amin Z, Freidman E, Vale J, Kirby RW, Lees WR. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol 1993; 48: 18–24.
- Mancini M, Bartolini M, Maggi M, Innocenti P. Villari N, Forti G. Duplex ultrasound evaluation of cavernosal peak velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl 2000; 23: 199–204.
- Montorsi F, Guazzoni G, Barbieri L, Ferini-Strambi L, Iannaccone S, Calori G, et al. Genital plus audiovisual sexual stimulation following intracavemous vasoactive injection versus re-dosing for erectile dysfunction-results of a prospective study. J Urol 1998; 159: 120–1.
- Erdogru T, Kadioglu A, Cayan S, Tellaloglu S. Does the positive intracavemous papaverine test always indicate a normal penile vascular system? Eur Urol 1997; 31: 323–8.
- Rahman MA. Pathophysiology of erectile dysfunction. In: Vaughan ED Jr, Perlmutter AP, eds. Atlas of clinical urology, Vol. 1. Philadelphia, PA: Current Medicine Inc, 1999: 1–16.
- Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on aetiology and response to prior treatment. J Urol 1999; 162: 722–5.
- Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ, et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire. Urology 2001; 57: 960–5.
- Sairam K, Kulinskaya E, Hanbury D, Boustead G, McNicholas T. Oral sildenafil (Viagra trademark) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital. BMC Urol 2002; 2: 4–11.
- Basar M, Tekdogan UY, Yilmaz E, Basar H, Atan A, Batislam E. The efficacy of sildenafil in different aetiologies of erectile dysfunction. Int Urol Nephrol 2001; 32: 403–7.
- Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397–404.